Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) by Gerrit Reepmeyer
Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) by Gerrit Reepmeyer PDF, ePub eBook D0wnl0ad
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously. Particularly if a company is highly dependent on just a handful of mega-selling blockbuster drugs, the risks can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical companies have started to organize their R&D in partnership. In fact, more than 600 alliances in pharmaceutical R&D are signed every year.From reader reviews:
Douglas Barney:
Do you considered one of people who can't read pleasurable if the sentence chained inside straightway, hold on guys this aren't like that. This Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) book is readable by simply you who hate those perfect word style. You will find the data here are arrange for enjoyable reading through experience without leaving possibly decrease the knowledge that want to provide to you. The writer regarding Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) content conveys thinking easily to understand by a lot of people. The printed and e-book are not different in the information but it just different such as it. So , do you nonetheless thinking Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) is not loveable to be your top record reading book?
Patricia Frazier:
The guide with title Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) posesses a lot of information that you can study it. You can get a lot of benefit after read this book. This specific book exist new understanding the information that exist in this e-book represented the condition of the world currently. That is important to yo7u to be aware of how the improvement of the world. This particular book will bring you throughout new era of the syndication. You can read the e-book with your smart phone, so you can read the idea anywhere you want.
Bruce Patton:
Reading a book make you to get more knowledge from this. You can take knowledge and information from the book. Book is created or printed or created from each source this filled update of news. With this modern era like right now, many ways to get information are available for anyone. From media social just like newspaper, magazines, science e-book, encyclopedia, reference book, book and comic. You can add your understanding by that book. Isn't it time to spend your spare time to spread out your book? Or just searching for the Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) when you essential it?
Read Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) by Gerrit Reepmeyer for online ebook
Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) by Gerrit Reepmeyer Free PDF d0wnl0ad, audio books, books to read, good books to read, cheap books, good books, online books, books online, book reviews epub, read books online, books to read online, online library, greatbooks to read, PDF best books to read, top books to read Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing (Contributions to Management Science) by Gerrit Reepmeyer books to read online.
No comments:
Post a Comment